bioAffinity Technologies Inc (BIAF)

Currency in USD
8.930
-6.340(-41.52%)
Closed·
8.770-0.160(-1.79%)
·

bioAffinity Technologies Inc Company Profile

bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. The company operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person’s sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have shed from a lung tumor. The company has a collaboration with Brooke Army Medical Center to evaluate its proprietary tests under development to identify inflammatory biomarkers for asthma and chronic obstructive pulmonary disease. bioAffinity Technologies, Inc. was incorporated in 2014 and is based in San Antonio, Texas.

Contact Information

Address
3300 Nacogdoches Road Suite 216, San Antonio, 78217, United States
Phone
210 698 5334

Top Executives

Name
Title
Since
Age
Steven GirgentiFounder & Executive Chairman of the Board201480
Maria ZannesFounder, President, CEO & Director201470
Peter Sage KnightIndependent Director201875
Jamie PlattIndependent Director202359
Roberto RiosIndependent Director202568
Neil AlexisMember of Science & Medical Advisory Board--
David G. HillMember of Science & Medical Advisory Board2022-
Sheila HabibMember of Scientific & Medical Advisory Board2022-
Sandeep BansalMember of Science & Medical Advisory Board2024-
John J. OppenheimerIndependent Director202565
David OstMember of Medical & Scientific Advisory Board2026-
Daniel H. StermanMember of Medical & Scientific Advisory Board2026-
J. Scott FergusonMember of Medical & Scientific Advisory Board2026-
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.